Email Alert | RSS    帮助

中国防痨杂志 ›› 2018, Vol. 40 ›› Issue (5): 506-511.doi: 10.3969/j.issn.1000-6621.2018.05.013

• 论著 • 上一篇    下一篇

耐多药及广泛耐药MTB菌株对SQ109的耐药性及其与北京基因型的关系

董文竹,王政,文舒安,张婷婷,霍凤敏,董玲玲,李云絮,赵立平,黄海荣,高飞(),逄宇()   

  1. 010059 呼和浩特,内蒙古医科大学[董文竹(在读研究生)];首都医科大学附属北京朝阳医院呼吸与危重症医学科(王政);首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所国家结核病临床实验室[文舒安(在读研究生)、张婷婷(在读研究生)、霍凤敏、董玲玲、李云絮、赵立平、黄海荣、逄宇];内蒙古自治区第四医院 内蒙古自治区感染性疾病医疗质控中心(高飞)
  • 收稿日期:2018-03-14 出版日期:2018-05-10 发布日期:2018-06-12
  • 通信作者: 高飞,逄宇 E-mail:gaofeiwho@163.com;pangyupound@163.com
  • 基金资助:
    北京市优秀人才培养资助青年拔尖人才项目(2017000021223ZK39);国家自然科学基金青年科学基金(81600070)

Resistance of MDR-TB and XDR-TB strains to SQ109 and the relationship with Beijing genotypes

Wen-zhu DONG,Zheng WANG,Shu-an WEN,Ting-ting ZHANG,Feng-min HUO,Ling-ling DONG,Yun-xu LI,Li-ping ZHAO,Hai-rong HUANG,Fei GAO(),Yu PANG()   

  1. Inner Mongolia Medical University, Hohhot 010059, China
  • Received:2018-03-14 Online:2018-05-10 Published:2018-06-12
  • Contact: Fei GAO,Yu PANG E-mail:gaofeiwho@163.com;pangyupound@163.com

摘要:

目的 评价耐多药(MDR)及广泛耐药(XDR)MTB菌株对抗结核新药乙胺丁醇(EMB)类似物SQ109的耐药性,为SQ109的临床应用提供依据。方法 收集首都医科大学附属北京胸科医院2014年7月至2016年12月临床分离培养阳性的MTB菌株,共计223株,包括MDR菌株109株,XDR菌株114株。采用微孔板阿尔玛蓝显色法检测SQ109对菌株的最低抑菌浓度(MIC),确定流行病学界值(ECOFF值);采用RD207基因作为北京基因型和非北京基因型的分离标准进行基因型鉴别,并比较不同基因型菌株耐药情况;根据临床药物敏感性试验(简称“药敏试验”)结果将菌株对EMB的耐药情况进行分类,并比较EMB耐药菌株和敏感菌株对SQ109耐药率的差异。结果 根据临床MTB菌株对于SQ109的MIC值频数分布情况,确定ECOFF值为1.000mg/L。XDR菌株耐药率为4.4%(5/114),MDR菌株中无耐药菌株,两者耐药率差异无统计学意义(Fisher精确概率法,P>0.05)。109株MDR菌株中有8株非北京基因型,114株XDR中有10株非北京基因型。北京基因型菌株对SQ109耐药率为2.4%(5/205),非北京基因型菌株中未发现耐药菌株,两者耐药率差异无统计学意义(Fisher精确概率法,P>0.05)。223株菌株中共有138株EMB敏感菌株和85株EMB耐药菌株。EMB敏感菌株对SQ109耐药菌株数为1株,耐药率为0.7%(1/138);EMB耐药菌株对SQ109耐药菌株数为4株,耐药率为4.7%(4/85),两者耐药率差异无统计学意义(Fisher精确概率法,P>0.05)。结论 SQ109在体外药敏试验中表现出对MDR-MTB和XDR-MTB菌株具有良好的抑菌效果。北京基因型菌株与SQ109耐药性无相关性。菌株对EMB的耐药性与对SQ109的耐药性无相关性。

关键词: 分枝杆菌, 结核, 抗药性, 多种, 细菌, 基因型, 因果律, SQ109

Abstract:

Objective To evaluate the susceptibility of multi-drug resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) strains against SQ109, an analogue of ethambutol (EMB, a new anti-TB drug), and to provide evidence for the clinical application of SQ109.Methods Two hundred and twenty three strains including 109 MDR-TB and 114 XDR-TB were collected from the patients seeking health care in Beijing chest hospital from July 2014 to December 2016. The minimum inhibitory concentrations (MIC) of MTB isolates against SQ109 were detected by broth dilution micro-plate alamar blue assay. The epidemiological cutoff (ECOFF) value was determined on the basis of distribution of MIC values. RD207 gene was used to distinguish Beijing genotype and non-Beijing genotype. Difference in SQ109 resistance rates between groups was compared. According to the results of clinical drug sensitivity test, the EMB resistant strains were isolated, and SQ109 resistance rate was compared between EMB resistant and sensitive strains.Results The ECOFF value was determined to be 1.000 mg/L according to the frequency distribution of MIC against SQ109. The resistance rate was 4.4% (5/114) and 0.0% among XDR-TB and MDR-TB isolates, respectively. There was no statistical difference in SQ109-resisitant rate between MDR-TB and XDR-TB (Fisher exact probabilities, P>0.05). Eight isolates out of 109 MDR strains and 10 isolates out of 114 XDR strains were classified as non-Beijing genotype. The resistant rate of the Beijing geno-type strain was 2.4% (5/205), while no non-Beijing genotype strain harbored SQ109 resistance. Statistical analysis revealed that no significant difference was observed in SQ109 resistance rate between Beijing and non-Beijing group (Fisher exact probabilities, P>0.05). Of the 223 strains, there were 138 EMB sensitive strains and 85 EMB resistant strains. Among EMB sensitive strains, only one was resistant strain against SQ109, and the resistance rate was 0.7% (1/138). Among the EMB resistant strains, 4 strains were resistant to SQ109, and the resistance rate was 4.7% (4/85). The difference in SQ109 resistance rate between EMB sensitive and resistant strains was not statistically significant (Fisher exact probabilities, P>0.05).Conclusion SQ109 exhibits favorable efficacy against MDR- and XDR-TB isolates in vitro. In addition, there is no statistical correlation between SQ109 resistance and Beijing genotype or between EMB resistance and SQ109 resistance.

Key words: Mycobacterium tuberculosis, Drug resistance, multiple, bacterial, Genotype, Causality, SQ109